I am addressing you as the Commissioning Editor of the journal Immunotherapy, published by Future Medicine Ltd. Immunotherapy was launched in January 2009 and is a monthly forum for reviews and original research, augmented with commentary and analysis from international experts, published in both print and online formats. The journal is indexed in PubMed/Medline and Thomson?s Science Citation Index Expanded (impact factor 0.542).

Articles published in Immunotherapy include key areas such as cancer immunotherapy, restorative immunotherapy for immunocompromised patients, suppressive immunotherapy for autoimmunity diseases and transplantation, vaccines, basic science of immunotherapeutic approaches, as well as results of recent findings and clinical trials relevant to the field of immunotherapy. Within the scope of our journal are problems of fields of immunotherapy for allergic diseases.

I am inviting you to contribute an article to Immunotherapy. We publish various article types, such as Editorials, Primary Research, Reviews and Perspectives, and I would be very happy to hear from you should you wish to submit an article at any point. In the first instance, please email me a very brief summary, together with a working title and author names. Please also state which type of article you intend to submit. All articles are subject to rigorous peer-reviewing. Following publication, all corresponding authors will receive a complimentary copy of the journal to which the article is published. In addition, for authors from the academia, we offer a free 1-year personal online subscription to the journal upon publication. To register your institution for a free 30-day trial access to Immunotherapy, simply contact Adres poczty elektronicznej jest chroniony przed robotami spamującymi. W przeglądarce musi być włączona obsługa JavaScript, żeby go zobaczyć. with your details and quote reference TRIAL11.

If you have any questions at all, or need more information on the journal or article types,
please do not hesitate to contact me.

With my best regards,

Duc H. Le, PhD
Commissioning Editor

Future Medicine Ltd
Unitec House
2 Albert Place
London N3 1QB, UK
T: +44 (0)20 8371 6090
F: +44 (0)20 8371 6099
E: Adres poczty elektronicznej jest chroniony przed robotami spamującymi. W przeglądarce musi być włączona obsługa JavaScript, żeby go zobaczyć.

PO POLSKU